con kaiden on game con research spending by governments in the pharmaceutical sector has been rising for years their aim is to achieve the e.u.'s lisbon target of 3 percent of gross domestic product germany austria and switzerland together and . asked about 120000000000 euros in research and development every year. however those affected by rare diseases do not automatically benefit the pharmaceutical industry applies a simple formula. for you i think history class how common or how rare is the disease he is there any basic research that shows how it could be treated. or can and can we expect research into it to pay off at some point. but i think you can find. many people affected by rare diseases a hope for new drugs or gene therapy s but it's a complex process scientists must 1st find and develop an active substance then they tested on animals so as not to endanger humans. these studies alone often take years. and then when all the trials have gone well if you go into clinical trials that is into research with actual patients initially healthy volunteers will be thinking. of around